CompanyProfileNomu

Actions

Al-Modawat Specialized Medical Co.

9594
ALMODAWAT
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Nomu - Parallel Market
  • Health Care Equipment & Svc

Stats Overview

  • Prev. Close 149.00
  • Open -
  • High -
  • Low -
  • No. Of Trades -
  • Avg. Trade size* N/A
  • Volume Traded -
  • Value Traded -

Performance

ALMODAWAT
0.00 ( - )
Compare
Name Price Change %
Al-Modawat Specialized Medical Co. 0.00 -
Quote delayed by 5 mins
  • *Average Trade Size = Cumulative / # of Trades
  • **52 Week Price Change =   (Current Price - Price year ago) / Price year ago x 100
  • Historical prices & volume traded data are adjusted to account for all corporate actions.
  • MO: Market Order

Trade Updates

Trade Updates

Price
-
% Change
-
Volume Traded
-

Best Bid

Price 146.00
Volume 265

Best Offer

Price 149.00
Volume 50

52 WEEK

High
154.60
2024/04/21
Low
98.00
2024/02/26
change
0.0

PERFORMANCE

Start of Year
105.4
Year ago
3 Years ago

Compare Selected

Select A Maximum Of 5 Companies

Compare Selected

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

AnnouncmentandCorporateAction

Actions
Jump To :
  • Announcements & Corporate Actions
  • Dividends
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Announcements

  • Al-Modawat Specialized Medical Co. announces the Board of Directors’ recommendation to purchase its shares and retain them as treasury shares

    9594
    ALMODAWAT 0.0 %
    1445/10/05     14/04/2024 08:30:00
  • Al-Modawat Specialized Medical Co. Announces Calling Candidature for Board Members Elections

    9594
    ALMODAWAT 0.0 %
    1445/09/23     02/04/2024 08:20:03
  • Al-Modawat Specialized Medical Co. announces the board of director’s recommendation to distribute cash dividends for The fiscal year ending on 12/31/2023

    9594
    ALMODAWAT 0.0 %
    1445/09/21     31/03/2024 22:47:05
  • Al-Modawat Specialized Medical Co. announces its Annual Financial results for the period ending on 2023-12-31

    9594
    ALMODAWAT 0.0 %
    1445/09/21     31/03/2024 16:14:20
  • Al-Modawat Specialized Medical Co. Announces Contract Sign Off with Cigalah healthcare llc /Purchase MRI Unit

    9594
    ALMODAWAT 0.0 %
    1445/09/15     25/03/2024 09:39:06
View All

Corporate Actions

Upcoming Events

    Past Events

      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Dividends

      Announced Date Eligibility Date Distribution Date Distribution Way Dividend Amount
      31/03/2024 N/A N/A Account Transfer 7.00

      CompanyProfileNomuv2Financials

      Actions
      Jump To:
      • Announcements & Corporate Actions
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Financials

      • FINANCIAL INFORMATION
      • FINANCIAL STATEMENTS AND REPORTS
      • Annually
      • Semi-Annual
      Balance Sheet
      Total Assets - - - -
      Total Liabilities - - - -
      Total Shareholders Equity (After Deducting the Minority Equity) - - - -
      Total Liabilities and Shareholders Equity - - - -
      Statement of Income
      Total Revenue (Sales/Operating) - - - -
      Net Profit (Loss) before Zakat and Tax - - - -
      Zakat and Income Tax - - - -
      Net Profit (Loss) after Zakat and Tax - - - -
      Total Comprehensive Income - - - -
      Profit (Loss) per Share - - - -
      Cash Flow
      Net Cash From Operating Activities - - - -
      Net Cash From Investing Activities - - - -
      Net Cash From Financing Activities - - - -
      Cash and Cash Equivalents, Beginning of the Period - - - -
      Cash and Cash Equivalents, End of the Period - - - -
      All Figures in
      All Currency In
      Last Update Date

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Balance Sheet
      Total Assets - - - -
      Total Liabilities - - - -
      Total Shareholders Equity (After Deducting the Minority Equity) - - - -
      Total Liabilities and Shareholders Equity - - - -
      Statement of Income
      Total Revenue (Sales/Operating) - - - -
      Net Profit (Loss) before Zakat and Tax - - - -
      Zakat and Income Tax - - - -
      Net Profit (Loss) after Zakat and Tax - - - -
      Total Comprehensive Income - - - -
      Profit (Loss) per Share - - - -
      Cash Flow
      Net Cash From Operating Activities - - - -
      Net Cash From Investing Activities - - - -
      Net Cash From Financing Activities - - - -
      Cash and Cash Equivalents, Beginning of the Period - - - -
      Cash and Cash Equivalents, End of the Period - - - -
      All Figures in
      All Currency In
      Last Update Date

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Display Previous Periods
      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Shareholding Information

      • Board Of Directors
      • Foreign Ownership
      • Substantial Shareholders
      Time Period
      -
      Search
      Trading Date Shareholders Designation Shares Held Trading Day Shares Held Prev Trading Day Change
      2024-04-23 عبدالله ابراهيم محمد اليحياء Chairman 3.9200000% 3.9200000% 0
      • The listed company (Publisher) shall be responsible for the accuracy of the published information pertaining to the ownership of the Board of Directors, Chief Executive Officer or highest executive position, and the Chief Financial Officer. The listed company shall also be responsible for updating these information thereof. Therefore, the Saudi Stock Exchange (Tadawul) shall not be liable for the information contained therein, nor for any consequences that may result from the said information.
      for
      subs
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Peer Comparison

      • Table
      • Graphical
      Add Company

      Compare Selected

      Select a Maximum of 5 Companies

      Company Apply
      Al-Modawat Specialized Medical Co.
      Price -
      Market Cap (SAR MN) 354
      P/E Ratio 19.04
      Index Name Index Level 1D Return
      Al-Modawat Specialized Medical Co. %
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Company Profile

      Company overview

      The current actual activity of the company is managing the hospital affiliated with the company. The hospital specializes in various medical fields, including cardiology, orthopedics, neurology, obstetrics and gynecology, ophthalmology, dermatology clinic, gastroenterology clinic and endoscopy, internal medicine, pediatrics, psychiatry, general surgery, emergency medicine, otolaryngology (ear, nose, and throat), general dentistry, pulmonology, intensive care, urology, laboratory department, and diagnostic radiology department.

      Company History

      a Saudi joint stock company closed according to Ministerial Resolution No. (G/11536) dated 08/09/1442 AH (corresponding to 20/04/2021 AD), and Ministerial Resolution No. (G/11537) dated 04/11/1442 AH (corresponding to 14/06/2021 AD), and according to Commercial Registration No. (5860065577) dated 24/01/1435 AH (corresponding to 20/08/2014 AD) issued in Riyadh,

      Company Bylaws

      Click here

      Equity Profile

      • Authorized Capital (SAR) 23,750,000
      • Issued Shares 2,375,000
      • Paid Up Capital (SAR) 23,750,000
      • Par Value/Share 10
      • Paid Up Value/Share 10

      Last Update :2024-02-25

      Investment limits

      There are no investment limits on the company's shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on Company's bylaw and the issued Instructions by related regulators and supervisory authorities.

       

      • Company Details
      • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
      • Date Established

        2014/08/20

      • Financial Year End

        31/12

      • Listing Date

        2024/02/25

      • External Auditors

        [Talal Abu- Ghazaleh & Co]

      • ISIN CODE

        SA161054LT11

      • Number of Employees

        255

      • Chairman

        Abdullah Ibrahem Mohammed Alyahya
        Non - Executive

        Abdullah Ibrahem Mohammed Alyahya
        • Bd Session Start
          2021-06-03
          Designation
          Chairman
        • Bd Session End
          2024-06-02
          Classification
          Non - Executive
      • Board of Directors

        Abdulrahman Ibrahem Mohammed Alyahya Deputy Chairman - Non Executive

        Abdulrahman Ibrahem Mohammed Alyahya
        • Bd Session Start
          2021-06-03
          Designation
          Board of Directors
        • Bd Session End
          2024-06-02
          Classification
          Deputy Chairman - Non Executive

        Fahad Mohammed Abdullah Alshehri Executive

        Fahad Mohammed Abdullah Alshehri
        • Bd Session Start
          2021-06-03
          Designation
          Board of Directors
        • Bd Session End
          2024-06-02
          Classification
          Executive

        Nawaf Hamzah Abdullah Bawazir Independent

        Nawaf Hamzah Abdullah Bawazir
        • Bd Session Start
          2022-08-28
          Designation
          Board of Directors
        • Bd Session End
          2024-06-02
          Classification
          Independent

        Hani Abduljalil Mohammed al-Hashemi Independent

        Hani Abduljalil Mohammed al-Hashemi
        • Bd Session Start
          2021-08-22
          Designation
          Board of Directors
        • Bd Session End
          2024-06-02
          Classification
          Independent

        Abdulaziz Ibrahem Mohammed Alyahya Executive

        Abdulaziz Ibrahem Mohammed Alyahya
        • Bd Session Start
          2021-06-03
          Designation
          Board of Directors
        • Bd Session End
          2024-06-02
          Classification
          Executive
      • Senior Executives

        Abdulaziz Ibrahem Mohammed Alyahya CEO

        Abdulaziz Ibrahem Mohammed Alyahya
        • Bd Session Start
          2022-04-27
          Designation
          Senior Executives
        • Bd Session End
          -
          Classification
          CEO

        Adel Mohamed Khattab CFO

      Adel Mohamed Khattab
      • Bd Session Start
        2023-12-11
        Designation
        Senior Executives
      • Bd Session End
        -
        Classification
        CFO

      Investor Relations

      Contact Name:

      Abdulaziz ibrahim mohamed alyahya

      Company Address:

      King Abdullah Bin Abdulaziz (3) PO Box 176, Postal Code 61913

      Contact Details:

      Telephone: 0172856666
      Fax: 0172851265
      Email: info@almodawat.sa

      Company Website:

      www.almodawat.sa


      Add To Watchlist
      In your Watchlist
      Add To Watchlist

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.